Symbolic interactionism

FTC Votes to Reverse Course on Repeal of Fabric Care Labels

Retrieved on: 
Saturday, July 24, 2021

Following that action, the FTC received more than 200 comments, with an overwhelming majority opposed to the repeal of the rule.

Key Points: 
  • Following that action, the FTC received more than 200 comments, with an overwhelming majority opposed to the repeal of the rule.
  • After careful consideration, I believe the record supports retaining the Care Labeling Rule and that it should not be rescinded.
  • Many individuals and small businesses opposed the repeal, emphasizing that buyers rely on labels to help extend the life of their clothes.
  • The Commission voted 5-0 to issue a statement to notify the public that it will not repeal the Care Labeling Rule, as previously proposed.

FTC Votes to Reverse Course on Repeal of Fabric Care Labels

Retrieved on: 
Saturday, July 24, 2021

Following that action, the FTC received more than 200 comments, with an overwhelming majority opposed to the repeal of the rule.

Key Points: 
  • Following that action, the FTC received more than 200 comments, with an overwhelming majority opposed to the repeal of the rule.
  • After careful consideration, I believe the record supports retaining the Care Labeling Rule and that it should not be rescinded.
  • Many individuals and small businesses opposed the repeal, emphasizing that buyers rely on labels to help extend the life of their clothes.
  • The Commission voted 5-0 to issue a statement to notify the public that it will not repeal the Care Labeling Rule, as previously proposed.

FTC Votes to Reverse Course on Repeal of Fabric Care Labels

Retrieved on: 
Saturday, July 24, 2021

Following that action, the FTC received more than 200 comments, with an overwhelming majority opposed to the repeal of the rule.

Key Points: 
  • Following that action, the FTC received more than 200 comments, with an overwhelming majority opposed to the repeal of the rule.
  • After careful consideration, I believe the record supports retaining the Care Labeling Rule and that it should not be rescinded.
  • Many individuals and small businesses opposed the repeal, emphasizing that buyers rely on labels to help extend the life of their clothes.
  • The Commission voted 5-0 to issue a statement to notify the public that it will not repeal the Care Labeling Rule, as previously proposed.

Satellite Healthcare Named to Parity.org Best Companies for Women to Advance List for Two Consecutive Years

Retrieved on: 
Wednesday, July 7, 2021

Satellite Healthcare, a not-for-profit kidney care company, has been named to the Parity.org Best Companies for Women to Advance List 2021.

Key Points: 
  • Satellite Healthcare, a not-for-profit kidney care company, has been named to the Parity.org Best Companies for Women to Advance List 2021.
  • Jeff Goffman, Satellite Healthcare CEO, expressed, Its an honor to be included on the Parity.org list for the second consecutive year.
  • The companies that are on the 2021 list of Best Companies for Women to Advance are shining examples of companies that actually walk the talk and are helping create equal representation, now.
  • Parity.org established the Best Companies for Women to Advance List to recognize organizations that have benefits, policies, and programs that are particularly beneficial for women to advance in the workplace.

Satellite Healthcare Names Industry Veteran Jeffrey Goffman as CEO

SAN JOSE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Satellite Healthcare, the leading nonprofit dialysis provider, today announced Jeffrey Goffman will be its next CEO, effective January 2, 2021.

Key Points: 
  • SAN JOSE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Satellite Healthcare, the leading nonprofit dialysis provider, today announced Jeffrey Goffman will be its next CEO, effective January 2, 2021.
  • Goffman brings nearly 30 years of health care industry leadership to Satellite, with expertise in physician practice management, large healthcare system joint ventures, ancillary services and value-based care models.
  • We are pleased to welcome Jeffrey Goffman as our next CEO, an industry veteran who understands the importance of expanding access to critical care services like dialysis, said Christobel Selecky, chair of the Satellite Healthcare Board of Directors.
  • Prior to Satellite, Goffman served as CEO of Integrated Oncology Network for more than a decade.

Labeling Equipment Market Procurement Report | Roadmap to Recovery for Businesses from the Impact of COVID-19 Pandemic | SpendEdge

Retrieved on: 
Monday, November 23, 2020

The new Labeling Equipment market research report from SpendEdge indicates an incremental growth during the forecast period as the business impact of COVID-19 spreads.

Key Points: 
  • The new Labeling Equipment market research report from SpendEdge indicates an incremental growth during the forecast period as the business impact of COVID-19 spreads.
  • View the full release here: https://www.businesswire.com/news/home/20201123005549/en/
    SpendEdge has announced the release of its Global Labeling Equipment Market Procurement Intelligence Report (Graphic: Business Wire)
    As the markets recover SpendEdge expects the Labeling Equipment market size to grow by USD 3 billion during the period 2020-2024.
  • Get detailed insights on the COVID-19 pandemic crisis and recovery analysis of the Labeling Equipment market.
  • Download free report sample
    Analysis of the cost and volume drivers and supply market forecasts in various regions are offered in this Labeling Equipment research report.

FDAnews Announces -- Drug, Biologics and Combination Products Labeling: Complying with FDA's Most Recent Guidance Webinar Nov. 13, 2020

Retrieved on: 
Friday, November 6, 2020

Alan G. Minsk, Esq.

Key Points: 
  • Alan G. Minsk, Esq.
  • a Partner and Leader of the Food & Drug Practice Team of Arnall Golden Gregory LLP will clarify the guidance and explain how to comply with it.
  • Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
    to learn about our special multisite discount.
  • Drug, Biologics and Combination Products Labeling:

Jay M. Goffman To Receive The 2020 M&A Advisor Lifetime Achievement Award

Retrieved on: 
Tuesday, February 25, 2020

NEW YORK, Feb. 25, 2020 /PRNewswire/ --The M&A Advisor is proud to announce that Jay M. Goffman is the recipient of the 2020 M&A Advisor Lifetime Achievement Award.

Key Points: 
  • NEW YORK, Feb. 25, 2020 /PRNewswire/ --The M&A Advisor is proud to announce that Jay M. Goffman is the recipient of the 2020 M&A Advisor Lifetime Achievement Award.
  • Mr. Goffman also played a leading role in Charter Communications' prearranged restructuring, representing Paul Allen as the owner.
  • "We are excited to present Jay M. Goffman with the 2020 M&A Advisor Lifetime Achievement Award," said Roger Aguinaldo, Founder of The M&A Advisor.
  • The M&A Advisor was founded in 1998 to offer insights and intelligence on mergers and acquisitions through the industry's leadingpublication.

Mercedes-Benz USA and Mattel Tackle Gender Stereotypes with 50,000 Girls and a Toy Car

Retrieved on: 
Friday, November 8, 2019

Kicking off today for National STEM/STEAM Day, 50,000 young girls across the nation will engage in programs to challenge gender stereotypes that research shows can impact decisions later in life.

Key Points: 
  • Kicking off today for National STEM/STEAM Day, 50,000 young girls across the nation will engage in programs to challenge gender stereotypes that research shows can impact decisions later in life.
  • Weve seen that stories like Ewys championing women trailblazers and achievers can have a big impact by calling into question the gender stereotypes that children may inadvertently adopt.
  • In fact, according to the National Science Board, women only represent 29% of the current science and engineering workforce.
  • We applaud Mercedes-Benz and Mattel in their efforts to breakdown the gender stereotypes that keep young girls from engaging in STEM studies.

AtriCure Receives Clearance for Expanded Labeling Claims for AtriClip Devices

Retrieved on: 
Tuesday, August 27, 2019

AtriClip devices are the most widely implanted left atrial appendage management devices on the market, having been used in more than 190,000 procedures worldwide.

Key Points: 
  • AtriClip devices are the most widely implanted left atrial appendage management devices on the market, having been used in more than 190,000 procedures worldwide.
  • These new labeling claims reflect that AtriClip devices exclude the appendage resulting in eliminating it as a source of electrical activity through the process of ischemic necrosis.
  • We continue to demonstrate our leadership in the LAA management space by expanding our labeling claims for AtriClip devices, said Michael Carrel, President and Chief Executive Officer of AtriCure.
  • Over the past several years, we have incrementally expanded our labeling to reflect the growing clinical use for AtriClip devices.